COVID-19 Patients Suffer From DHEA-S Sufficiency

Authors

  • Arezou Rezaei Institute of Biological Sciences, School of Biology, Damghan University, Damghan, Iran.
  • Behnaz Gharegozlou Department of Immunology, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Maryam Rajabnia Chenary Defense Health Research Center, Tehran, Iran.
  • Mohammad Mehdi Naghizadeh Immunoregulation Research Center, Shahed University, Tehran, Iran
  • Saeed Mohammadi Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Tooba Ghazanfari Immunoregulation Research Center , Shahed University< Tehran, Iran
Abstract:

Background: The nervous, endocrine, and immune systems contribute to the response and dynamic adaption to various stresses. Activation of the hypothalamic-pituitary-adrenal axis has been demonstrated in various active critical illnesses. Novel Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), is a disease with age and gender disparities. Materials and Methods: In this study, a total of 125 consecutive inpatients with COVID-19 admitted to Imam Khomeini Hospital Complex from February 12, 2020, to April 4, 2020, were enrolled. The severity of patients was classified into three subgroups based on the types of oxygen therapies. Dehydroepiandrosterone Sulfate (DHEA-S) and cortisol levels were measured in serum of inpatients with Siemens kit. Results: While the increase in cortisol level was not significant in COVID-19 patients, the DHEA-S level and DHEA-S/cortisol ratio significantly decreased in the patients with the increase in severity of the disease.Conclusion: We proposed that the supplementation of DHEA, the precursor of both androgens and steroids, may ameliorate adverse outcomes of COVID-19 disease and improve COVID-19 patients’ ability to survive.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

The Relationship between Work Ability and Severity of Disease in Patients Recovering from Covid-19

Introduction. The work ability index based on a person 's health statuse predicts the ability to continue working now and in near feature.  proper assessment of work ability in covid 19 recoveries is important for both patients and employers and its enhancement leads to the efficiency of human resourses in industries and organizations. The working staff’s efficiency is a matter of their work ab...

full text

Evaluatiom of Health Worker Education to Patients Recovered from COVID-19

Background & Purpose:: The covid-19 pandemic imposes a significant burden on healthcare systems. Proper self-care practice in people can reduce the pressure on the medical staff and save time and expenses for the patients. We assessed the quality of self-care education of healthcare worker from the viewpoint of patients recovered from COVID-19. Materials & Method: This cross-sectional study wa...

full text

Lived experiences of patients recovered from Covid-19: An interpretive phenomenological study

Background & Aim: Covid-19 is an emerging disease that has become a health crisis in the world and affected various aspects of human’s life. Understanding the experience of patients with this disease is essential for proper and comprehensive care. The aim of this study was to explore the lived experiences of patients recovered from Covid-19. Methods & Materials: The present study was a qualita...

full text

Neglectful Psychological Interventions Among Patients With Covid 19

Telephone or social media follow-up is important for patients who are referred to home quarantine after receiving a positive corona test. The outbreak of Covid-19 has caused concern among the general population around the world. Many people may be anxious and scared, and those who are directly affected by the virus in different ways may experience more panic, fear, and anxiety. All those who a...

full text

COVID-19 and its Outcomes in Multiple Sclerosis Patients

Background: Coronavirus Disease 2019 (COVID-19) is a highly contagious disease that resulted in 4533645 deaths until September first, 2021. Multiple Sclerosis (MS) patients receive immunosuppressive drugs. Thus, there is a concern that these drugs will reduce the patient’s immune system resistance against COVID19. Objectives: This study aimed to evaluate the epidemiology of COVID19 and its ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 3  issue 2

pages  135- 144

publication date 2020-01-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023